|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 440 First Street NW, Suite 700 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2000 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 22781-1003275
|
||||||||
|
6. House ID# 304420041
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: April L. Burke, President |
Date | 1/23/2017 9:01:55 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Higher Education Act Reauthorization, Issues pertaining to accreditation, affordability, student aid programs, grant programs, reporting requirements, and Hispanic Serving institutions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Julie |
Rose |
|
|
|
Naomi |
Webber |
|
|
|
Erin |
Cadwalader |
|
|
|
Lauren |
Broccoli |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Paula |
Trimble |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
P.L. 114-254, Further Continuing and Security Assistance Appropriations Act, 2017, Issues pertaining to FY 2017 funding for all federal agencies.
H.R. 5926, S. 3040, FY 2017 Labor/HHS/Education Appropriations, Issues pertaining to funding for NIH, AHRQ, Title VII and VIII health professions, education research, and federal student aid.
H.R. 5055, S. 2804, FY 2017 Energy/Water Appropriations, Issues pertaining to research, development, and education at DOE.
H.R. 5393, S. 2837, FY 2017 Commerce/Justice/Science Appropriations, Issues pertaining to high performance computing research and education at NSF, NOAA, NIST, NASA, and EDA.
H.R. 5293, S. 3000, FY 2017 Defense Appropriations, Issues pertaining to research and development at the Department of Defense.
H.R. 5054, S. 2956, FY 2017 Agriculture, Rural Development, FDA Appropriations, Issues pertaining to USDA research and related programs.
H.R. 5394, S. 2844, FY 2017 Transportation, Housing and Urban Development, and Related Agencies Appropriations, Issues pertaining to research funding for the Department of Transportation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Julie |
Rose |
|
|
|
Naomi |
Webber |
|
|
|
Erin |
Cadwalader |
|
|
|
Lauren |
Broccoli |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Paula |
Trimble |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2124, S. 1148, Resident Physician Shortage Reduction Act of 2015, Issues pertaining to the training of residents.
H.R. 4774, Training Tomorrow's Doctors Today Act, Issues pertaining to the training of residents.
Issues pertaining to protecting funding for direct graduate medical education and indirect medical education.
H.R. 5273, Helping Hospitals Improve Patient Care Act, Issues pertaining to hospital outpatient departments payments for off-campus departments.
H.R. 1343, S. 688, Establishing Beneficiary Equity in the Hospital Readmission Program Act of 2015, Issues pertaining to adjustment for socioeconomic status in the hospital readmissions program.
Issues relating to the proposed Medicare Part B Drug Model.
Issues relating to the implementation of MACRA.
Issues pertaining to the implementation of provisions regarding the treatment of off-campus hospital departments and site neutral payments.
Issues pertaining to protecting Medicaid.
Issues pertaining to protecting Disproportionate Share Hospital Payments.
Issues pertaining to the protection of reimbursements for safety net hospitals.
Issues pertaining to the CMS Center for Medicare and Medicaid Innovation and the University of Illinois Coordination of HealthCare for Complex Kids Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Naomi |
Webber |
|
|
|
Erin |
Cadwalader |
|
|
|
Lauren |
Broccoli |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Paula |
Trimble |
|
|
|
Julie |
Rose |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
P.L. 114-329 American Innovation and Competitiveness Act, Issues pertaining to NSF, NIST, and EDA.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Science Foundation (NSF)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Naomi |
Webber |
|
|
|
Erin |
Cadwalader |
|
|
|
Lauren |
Broccoli |
|
|
|
Julie |
Rose |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Paula |
Trimble |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
P.L. 114-328, National Defense Authorization Act for Fiscal Year 2017, Issues pertaining to Department of Defense science and technology programs, workforce, and acquisition policies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Erin |
Cadwalader |
|
|
|
Julie |
Rose |
|
|
|
Lauren |
Broccoli |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Naomi |
Webber |
|
|
|
Paula |
Trimble |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
P.L. 114-255, 21st Century Cures, Issues related to NIH funding and biomedical research, and issues pertaining to hospitals.
S. 2742, Promoting Biomedical Research and Public Health for Patients Act, Issues related to biomedical research and reducing administrative burden.
Issues related to NIH funding and biomedical research.
Issues pertaining to the 340B drug pricing program.
Issues pertaining to protecting maintaining access to affordable healthcare through the Patient Protection and Affordable Care Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Burke |
|
|
|
Michael |
Ledford |
|
|
|
Naomi |
Webber |
|
|
|
Erin |
Cadwalader |
|
|
|
Julie |
Rose |
|
|
|
Kaetlyn |
Cordingley |
|
|
|
Paula |
Trimble |
|
|
|
Lauren |
Broccoli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |